Indication
Pulmonary emphysema
Pulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD). Read more about Pulmonary emphysema
51 drugs 40 manufacturers
Drugs that treat it
Common Pulmonary emphysema therapies.
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
TERBUTALINE SULFATE
THEOPHYLLINE ER (theophylline anhydrous)
THEOPHYLLINE ER (theophylline anhydrous)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD).
Pathophysiologically, it is characterized by the irreversible enlargement of the air spaces distal to the terminal bronchioles, accompanied by the destruction of alveolar walls and a loss of lung elastic recoil.
This destruction impairs alveolar capillary gas exchange and leads to dynamic air trapping and lung hyperinflation.
Clinically, affected individuals present with persistent, exertional dyspnea, wheezing, reduced exercise tolerance, and a chronic cough, frequently arising from long-term tobacco smoke exposure or environmental irritants, as well as genetic conditions such as alpha-1 antitrypsin deficiency.
- nih.gov
Pulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD) Pathophysiologically, it is characterized by the irreversible enlargement of the air spaces distal to the terminal bronchioles, accompanied by the destruction of alveolar walls and a loss of lung elastic recoil This destruction impairs alveolar capillary gas exchange and leads to dynamic air trapping and lung hyperinflation Clinically, affected individ...
- medlineplus.gov
Pulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD) Clinically, affected individuals present with persistent, exertional dyspnea, wheezing, reduced exercise tolerance, and a chronic cough, frequently arising from long-term tobacco smoke exposure or environmental irritants, as well as genetic conditions such as alpha-1 antitrypsin deficiency
- hopkinsmedicine.org
Pulmonary emphysema is a chronic, progressive lower respiratory condition and a primary component of chronic obstructive pulmonary disease (COPD) This destruction impairs alveolar capillary gas exchange and leads to dynamic air trapping and lung hyperinflation Clinically, affected individuals present with persistent, exertional dyspnea, wheezing, reduced exercise tolerance, and a chronic cough, frequently arising from long-term tobacco smoke exposure or environmental irritants, as well as geneti...
- nih.gov
Pathophysiologically, it is characterized by the irreversible enlargement of the air spaces distal to the terminal bronchioles, accompanied by the destruction of alveolar walls and a loss of lung elastic recoil
- respiratory-therapy.com
Pathophysiologically, it is characterized by the irreversible enlargement of the air spaces distal to the terminal bronchioles, accompanied by the destruction of alveolar walls and a loss of lung elastic recoil
Personalize your experience
Follow Pulmonary emphysema and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.